Håkan Nordlander
Director of Finance/CFO at ExThera AB
Profile
Håkan Nordlander is currently the Chief Financial Officer at ExThera AB.
Previously, he worked as a Principal at AstraZeneca AB.
Håkan Nordlander active positions
| Companies | Position | Start |
|---|---|---|
ExThera AB
 ExThera AB Pharmaceuticals: MajorHealth Technology ExThera AB commercializes medical products. manufactures medical products in both in vitro and in vivo studies. Its products include Ekoral-S the biocompatible mouth-rinse, ExT-M for treatment of oral mucositis, meeting unmet medical needs, and pipeline of additional new products. The company was founded by Karl Olov Peter Larm in 2003 and is headquartered in Stockholm, Sweden. | Director of Finance/CFO | - |
Former positions of Håkan Nordlander
| Companies | Position | End |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
ExThera AB
ExThera AB Pharmaceuticals: MajorHealth Technology ExThera AB commercializes medical products. manufactures medical products in both in vitro and in vivo studies. Its products include Ekoral-S the biocompatible mouth-rinse, ExT-M for treatment of oral mucositis, meeting unmet medical needs, and pipeline of additional new products. The company was founded by Karl Olov Peter Larm in 2003 and is headquartered in Stockholm, Sweden. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Håkan Nordlander
